Overview

Carotid Plaque Assessment Using 18Fluorine (18F) -Sodium Fluoride Positron Emission Tomography (PET) /MR

Status:
Completed
Trial end date:
2017-12-12
Target enrollment:
0
Participant gender:
All
Summary
Carotid plaque can lead to ischemic stroke. Treatment of asymptomatic carotid plaque, based on degree stenosis, is still controversial. Beyond the degree of stenosis, the composition of the plaque could reflect the vulnerability and the risk of ipsilateral ischemic stroke. Identification of new predictive factor of ipsilateral ischemic stroke in patients with carotid plaque could help to screen high risk patients and to guide the treatment. The aim of the study is to assess 18F-sodium fluoride uptake among carotid plaque in recently symptomatic and asymptomatic patients. Investigators conduct a pilot case-control study. Twelve patients (6 recently symptomatic and 6 asymptomatic) with carotid stenosis (≥50% NASCET) will have a 18F-sodium fluoride PET/MR. Standardized uptake value (SUV) and tissue-to-background ratio (TBR) will be measured among carotid plaques.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hospices Civils de Lyon
Treatments:
Fluorides
Listerine
Sodium Fluoride
Criteria
Inclusion Criteria symptomatic patients:

- age>18

- Carotid plaque ≥ 50% symptomatic (ischemic stroke on CT or MR) during the last 15 days
or asymptomatic

- ability to give informed consent

- affiliation to social security

Exclusion Criteria:

- Modified Rankin score ˃ 3

- Contraindication to MRI

- Renal failure (creatinine clearance by cockcroft ˂ 50 ml / min)

- Pregnancy / Breastfeeding

- Hypersensitivity to the active substance or excipients